ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 127 filers reported holding ANI PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $193,804 | +55.0% | 3,338 | +43.7% | 0.00% | 0.0% |
| Q2 2023 | $125,047 | +121.5% | 2,323 | +63.5% | 0.00% | – |
| Q1 2023 | $56,442 | +76.7% | 1,421 | +79.0% | 0.00% | – |
| Q4 2022 | $31,943 | +22.9% | 794 | 0.0% | 0.00% | – |
| Q3 2022 | $26,000 | +8.3% | 794 | 0.0% | 0.00% | – |
| Q2 2022 | $24,000 | +9.1% | 794 | 0.0% | 0.00% | – |
| Q1 2022 | $22,000 | -40.5% | 794 | 0.0% | 0.00% | – |
| Q4 2021 | $37,000 | +42.3% | 794 | 0.0% | 0.00% | – |
| Q3 2021 | $26,000 | -7.1% | 794 | 0.0% | 0.00% | – |
| Q2 2021 | $28,000 | -3.4% | 794 | 0.0% | 0.00% | – |
| Q1 2021 | $29,000 | +26.1% | 794 | 0.0% | 0.00% | – |
| Q4 2020 | $23,000 | +4.5% | 794 | 0.0% | 0.00% | – |
| Q3 2020 | $22,000 | -15.4% | 794 | 0.0% | 0.00% | – |
| Q2 2020 | $26,000 | -18.8% | 794 | 0.0% | 0.00% | – |
| Q1 2020 | $32,000 | -34.7% | 794 | 0.0% | 0.00% | – |
| Q4 2019 | $49,000 | -15.5% | 794 | 0.0% | 0.00% | – |
| Q3 2019 | $58,000 | -10.8% | 794 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $65,000 | +282.4% | 794 | +237.9% | 0.00% | – |
| Q1 2019 | $17,000 | +54.5% | 235 | 0.0% | 0.00% | – |
| Q4 2018 | $11,000 | -15.4% | 235 | 0.0% | 0.00% | – |
| Q3 2018 | $13,000 | -18.8% | 235 | 0.0% | 0.00% | – |
| Q2 2018 | $16,000 | +14.3% | 235 | 0.0% | 0.00% | – |
| Q1 2018 | $14,000 | -6.7% | 235 | 0.0% | 0.00% | – |
| Q4 2017 | $15,000 | +25.0% | 235 | 0.0% | 0.00% | – |
| Q3 2017 | $12,000 | +9.1% | 235 | 0.0% | 0.00% | – |
| Q2 2017 | $11,000 | -8.3% | 235 | 0.0% | 0.00% | – |
| Q1 2017 | $12,000 | -14.3% | 235 | 0.0% | 0.00% | – |
| Q4 2016 | $14,000 | -12.5% | 235 | 0.0% | 0.00% | – |
| Q3 2016 | $16,000 | +23.1% | 235 | 0.0% | 0.00% | – |
| Q2 2016 | $13,000 | +62.5% | 235 | 0.0% | 0.00% | – |
| Q1 2016 | $8,000 | -27.3% | 235 | 0.0% | 0.00% | – |
| Q4 2015 | $11,000 | +22.2% | 235 | 0.0% | 0.00% | – |
| Q3 2015 | $9,000 | – | 235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |